ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights
WINSTON-SALEM, N.C., Aug. 10, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage...
Read moreWINSTON-SALEM, N.C., Aug. 10, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage...
Read moreRecord Fundraising and Deployment Drives Double-Digit Revenue GrowthDALLAS, Aug. 10, 2023 (GLOBE NEWSWIRE) -- P10, Inc. (NYSE: PX), a leading private...
Read moreMILPITAS, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- View, Inc. (Nasdaq: VIEW, “View” or the “Company”), a leader in smart...
Read moreConference call and webcast on August 10, 2023 at 5 p.m. ETRADNOR, Pa., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Safeguard...
Read moreConference call begins today at 4:30 pm ETWEST LAFAYETTE, Ind., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV)...
Read moreFirst Patients Dosed in Phase 2a Clinical Trial of SLS009 (formerly GFH009) in Acute Myeloid Leukemia with Topline Data Expected...
Read moreNet loss for the first six months of 2023 decreased by 45% as compared to the same period in 2022Cash...
Read more-- Total Q2 revenue up 115% over prior year; 131% over Q1 2023 -- -- Company to host call at...
Read moreRecent Highlights: Net revenues of $8.1 million in the second quarter of 2023, up 12% year-over-yearGross systems shipped of 5,098,...
Read more– Evaluating a number of opportunities to diversify pipeline in precision oncology – – Submitted data abstracts for milademetan in...
Read more